Coexisting chronic conditions in the older population: Variation by health indicators

Alessandra Marengoni1, Sara Angleman2, Bettina Meinow2

  • 1Aging Research Center, NVS Department, Karolinska Institutet, Sweden; Stockholm University, Sweden; Department of Clinical and Experimental Sciences, University of Brescia, Italy.

Insights

The prevalence of coexisting chronic conditions in older adults varies significantly based on the health indicator used. Factors like age, sex, and education further influence these complex health patterns.

Area of Science:

  • Gerontology
  • Public Health
  • Epidemiology

Background:

  • Analyzing the prevalence and patterns of coexisting chronic conditions in older adults is crucial for understanding population health.
  • Older adults often present with multiple health issues, necessitating comprehensive assessment.

Purpose of the Study:

  • To investigate the prevalence and patterns of coexisting chronic conditions among older adults in Stockholm.
  • To examine how different health indicators capture the complexity of chronic conditions in this demographic.

Main Methods:

  • A cross-sectional study involving 3363 individuals aged 60 years and older in Stockholm.
  • Chronic conditions were assessed using multimorbidity (≥2 diseases), Cumulative Illness Rating Scale, polypharmacy (≥5 drugs), and complex health problems.

Main Results:

  • Prevalence of chronic conditions varied by indicator; multimorbidity affected 38% of 60-74 year olds and 76% of those ≥85.
  • Polypharmacy was also common, observed in 24.3% of 60-74 year olds and 59% of those ≥85.
  • Older age, female sex, and lower educational level were associated with higher prevalence of certain health indicators.

Conclusions:

  • The choice of health indicator significantly impacts the estimated prevalence of coexisting chronic conditions in older adults.
  • Age, sex, and education level are important factors that modify the presentation of complex health issues.
  • Utilizing diverse indicators is essential for accurately assessing and addressing the multifaceted health needs of the elderly population.
Abstract

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
345
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
330
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
314
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
801
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
311
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.1K